Blue Owl Capital

Portfolio Co Investors 2026 for Blue Owl Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Blue Owl Capital accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $1.9B. The median disclosed raise is $250M, and the largest is Illumio at $558M, ahead of QuVa Pharma ($381M) and Interos ($309M).

The names that recur most often on these co-invested cap tables are Blue Owl Capital (8 companies), Sanofi Ventures (2 companies), Thoma Bravo (1 company), Franklin Templeton (1 company), Hamilton Lane (1 company), Bain Capital (1 company). By latest disclosed round, the market skews Growth (2), Series D (2), Series F (1), IPO (1).

Best funded Blue Owl Capital companies

  1. Illumio — $558M (latest: Series F)
  2. QuVa Pharma — $381M
  3. Interos — $309M
  4. TG Therapeutics — $250M (latest: Growth)
  5. NodThera — $145M (latest: IPO)
  6. Split Software — $110M (latest: Series D)
  7. Star Therapeutics — $100M (latest: Series D)
  8. Coremont — $34M (latest: Growth)

Blue Owl Capital — related firms and companies (51)

Blue Owl Capital alternatives · All research reports